Depreciation of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly and annual Depreciation in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Depreciation for the quarter ending 31 Dec 2025 was $27,000, a 3.8% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Depreciation for the twelve months ending 31 Dec 2025 was $111,000, a 16% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2025 was $111,000, a 16% increase from 2024.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2024 was $96,000, a 43% increase from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2023 was $67,000, a 123% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $111,000 $27,000 +$1,000 +3.8% 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $110,000 $27,000 +$2,000 +8% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $108,000 $30,000 +$7,000 +30% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $101,000 $27,000 +$5,000 +23% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $96,000 $26,000 +$7,000 +37% 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $89,000 $25,000 +$6,000 +32% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $83,000 $23,000 +$8,000 +53% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $75,000 $22,000 +$8,000 +57% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $67,000 $19,000 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $19,000 +$13,000 +217% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $15,000 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $14,000 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $6,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3

Dianthus Therapeutics, Inc. /DE/ Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $111,000 +$15,000 +16% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $96,000 +$29,000 +43% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $67,000 +$37,000 +123% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $30,000 +$30,000 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $0 01 Jan 2021 31 Dec 2021 8-K 21 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.